[This review was originally posted at the Nieman Journalism Lab Flagyl For Sale, on Nov. 18, 2011.]

A fight for online freedom: A U.S. House committee hearing brought an important three-week old bill on Internet censorship to the spotlight this week. The Stop Online Piracy Act (a companion of the Senate's Protect IP Act), would allow content creators to shut down websites on which people hosted unauthorized copyrighted content, or linked to sites that did. The Atlantic has a good, kjøpe Flagyl på nett, köpa Flagyl online, quick explainer, and the advocacy group Fight for the Future has a sharp video illustrating its implications. If you want to go in-depth, Techdirt has the most thorough continuing coverage of the bill.

I'm only slightly exaggerating when I say that it seems as though pretty much everyone on the Internet hates this bill, Flagyl For Sale. Bunches of Internet giants oppose it — Google was a major testifier at this week's hearing (though its rep referenced the WikiLeaks payment blocks favorably, Buy Flagyl online cod, which concerned some) — Tumblr ran an online campaign against the bill by mock-censoring its users' dashboard screens, and loads of online commentators howled against it.

Here's why they're so upset: This bill could inflict a ton of collateral damage, some of which could be a crucial blow for free speech on the web. The New America Foundation's Rebecca MacKinnon summed up the objections to the bill well, arguing that it would handcuff tech startups, lead to political censorship, purchase Flagyl, and have a chilling effect on speech on the web in general. As Dan Gillmor put it in the Guardian: "The longer-range damage is literally incalculable, because the legislation is aimed at preventing innovation – and speech – that the cartel can't control. Flagyl For Sale, If this law had been passed years ago, YouTube could not exist today in anything remotely like the form it has taken."

As GigaOM's Mathew Ingram noted, you can't have the explosion of creative production, individual empowerment, and democratic potential of the Internet without the downsides of rampant copyright infringement. If you take away the latter, he argued, Where to buy Flagyl, you take away the former, too. And venture capitalist Brad Burnham made the interesting point that the architecture of the web is based on the assumption that there are more good actors out there than bad, an idea that this bill runs squarely against.

This bill poses some potential problems for journalism, too. Jessica Roy of 10, get Flagyl,000 Words outlined some of those issues, pointing out that articles could be censored for linking to sites with piracy information, and that citizen journalism and innovation could be stifled.

—

Twitter as one-way street: The Pew Research Center's Project for Excellence in Journalism released a report this week on the way news organizations use Twitter, and the results weren't pretty: News orgs, they found, were using Twitter predominantly as a way to simply broadcast their stories online, not taking much advantage of Twitter's interactive capabilities or its ability to link readers to a wide variety of sources, Flagyl For Sale. PEJ said the behavior was reminiscent of the link-phobic early days of the web, and the Lab's Megan Garber called it a "glorified RSS feed."

GigaOM's Mathew Ingram was particularly troubled by how little news orgs and their journalists asked readers for news tips and feedback, Flagyl pharmacy, and media consultant Terry Heaton said this Twitter-as-headline-feed pattern among news orgs is evidence that it really is all about the money. "If influencing public life is the goal, then readership is what matters, and there are many ways to efficiently deliver unbundled content via the Web," he wrote. "When forcing people to read our content within our infrastructure, then it’s clear that monetizing that content is more important than anything else." Amy Gahran of the Knight Digital Media Center, meanwhile, australia, uk, us, usa, tied the study to another Pew study that reinforced the value of personal recommendations over impersonal ones.

There was also quite a bit of talk on Twitter about the study's weaknesses, led largely by media scholars like USC's Robert Hernandez. Still, one j-prof, Where can i cheapest Flagyl online, Alfred Hermida of the University of British Columbia, pointed out that this report's findings do echo those of several previous studies, both academic and professional.

—

Occupy Wall Street and scooping the wire Flagyl For Sale, : New York police swooped in earlier this week to clear Zuccotti Park of Occupy Wall Street protesters, which in itself wasn't surprising: Similar sweeps have been done in numerous American cities. What drew particular attention among future-of-news folks was the way they did it — by blocking journalists from viewing the action and even arresting 26 of them across the country, of whom seven worked full-time for traditional news orgs and seven had NYPD press credentials. The New York Times and the Atlantic have the most thorough accounts of what went on, and you can check out video of one of the reporter arrests at the Times' The Local, buy cheap Flagyl no rx.

One interesting side story to emerge from those arrests began when AP staff members tweeted that their AP colleagues had been arrested before the news hit the wire. The AP sent out a stern memo admonishing its journalists to beat their own wire reports on Twitter, prompting the New York Times' Brian Stelter to ask, "Shouldn't the wire speed up?!" GigaOM's Mathew said news orgs should consider Twitter the newswire now, and Reuters' Anthony DeRosa argued that policies like the AP's (and Reuters') are the products of head-in-the-sand thinking. (The AP sent out another memo the next day explaining that its initial memo was more about the safety of its arrested reporters than anything.)

Elsewhere in Occupy-related media and tech ideas: The Atlantic's Alexis Madrigal kicked off a series of posts on technology's role in the Occupy protests with a creative description of Occupy as a type of API, ReadWriteWeb's Jon Mitchell praised Storify for its role in Occupy coverage, and New York Times freelancer Natasha Lennard explained why she's ditching the objectivity-based paradigm of the mainstream media to get involved with Occupy, Flagyl For Sale. Flagyl forum, —

Romenesko and online attribution: A few of the loose ends from Jim Romenesko's unceremonious departure from the Poynter Institute were tied up since last week's review: Poynter renamed Romenesko's blog MediaWire, and in an interview, Romenesko shed some light on his insistence on resigning: "I worked there for 12 years, and I'm supposed to spend my final days being supervised, having a babysitter, whatever. It just seemed a little bit humiliating."

Most notably, Flagyl long term, the Columbia Journalism Review's Erika Fry published the article resulting from the reporting that started this bizarre episode. In it, she argued that the attribution problems aren't limited to Romenesko, but are in part of a function of Poynter's move to longer — and, as she put it — "over-aggregated" posts. Purchase Flagyl online, Several Poynter faculty members also weighed in, with Roy Peter Clark providing the sharpest take: "The standards of attribution we still apply in print may in fact be outdated in the age of sampling, file sharing, and mash-ups."

Other media critics continued to defend Romenesko (Reuters' Jack Shafer) and rip Poynter (Terry Heaton, Felix Salmon). Flagyl For Sale, The Gender Report's Jasmine Linabary, meanwhile, wondered why we weren't seeing much attention paid to women commenting on the Romenesko story.

—

Amazon releases the Kindle Fire: Amazon released its much-anticipated Kindle Fire tablet this week, and the reviews were mixed, Flagyl price. (PaidContent has a quick roundup of some of the big reviewers.) It got panned by a few places (most notably Wired), but the general sentiment was that while the Fire can't match up the iPad and some of the other top-end tablets, it's still a decent deal at $200. As the New York Times' David Pogue put it: "The Fire deserves to be a disruptive, gigantic force — it’s a cross between a Kindle and an iPad, Flagyl without a prescription, a more compact Internet and video viewer at a great price. But at the moment, it needs a lot more polish."

A few other notes regarding the Fire: Time Inc. had five of its magazines on the Fire at its launch after some protracted negotiating, and Amazon has made the Fire's source code available to developers to encourage software experimentation, Flagyl For Sale. Wired's Steven Levy, meanwhile, had an in-depth discussion with Amazon's Jeff Bezos about the state of the company.

—

Reading roundup: Bunches and bunches of interesting little stories this week, Flagyl natural. Here are a few we haven't hit yet:

— A federal judge ruled late last week that Twitter has to hand over information about possible WikiLeaks supporters, one of whom, Icelandic member of Parliament Birgitta Jonsdottir, expressed her outrage in the Guardian over the decision's threat to civil rights. ReadWriteWeb's John Paul Titlow and GigaOM's Mathew Ingram were also among those concerned about the future of privacy online.

— A few advertising-related tidbits: Reuters' Felix Salmon summarized a fascinating talk Flagyl For Sale, he gave on the woeful state of online advertising and what to do about it, Wired looked at Twitter's efforts to make serendipity pay as an advertising model, and the Lab examined newspapers' advertising efforts on Twitter. Meanwhile, the New York Times ran an innovative cross-platform interactive ad that also mimicked its news content, which led ACES' Charles Apple and the Columbia Journalism Review's Clint Hendler to question its ethics. The Times told Hendler the ad couldn't realistically be confused with actual Times content.

— The Columbia Journalism Review explored a crucial issue in the changing news ecosystem — what happens to all the communities that aren't hubs for innovation? — with a series of pieces on Modesto, California.

— Also in CJR, Megan Garber wrote a fascinating article looking back at how journalism has viewed its future over the years. The University of Colorado's Steve Outing decided to add to that tradition of journalistic fortune-telling with his set of predictions about what online news will look like 20 years from now.

Similar posts: Cephalexin For Sale. Retin A No Rx. Flagyl No Rx. Purchase Cipro online no prescription. Synthroid class. Tramadol pharmacy.
Trackbacks from: Flagyl For Sale. Flagyl For Sale. Flagyl For Sale. Flagyl cost. Ordering Flagyl online. Online buying Flagyl hcl.

[This review was originally posted at the Nieman Journalism Lab Cephalexin For Sale, on Nov. 11, 2011.]

Google+ courts businesses: After banning businesses for its first four months, Google+ finally let them in this week, launching Google+ Pages, which gives accounts to business and groups. (Danny Sullivan of Search Engine Land put together the best walkthrough of what Pages are and how they work.) Businesses jumped right in, including, About Cephalexin, of course, news orgs: Breaking News put together a running list of news Pages, and one Fox News show announced it would do Hangouts with presidential candidates, starting with Mitt Romney next week.

As Business Insider explained, Google has a big carrot to draw businesses in: Direct Connect, which allows users to go directly to a business's Google+ Page if they the business's name preceded by a "+". Lost Remote's Cory Bergman (who also runs the Breaking News Google+ account) said businesses should also get some SEO mojo from users clicking +1 on their Google+ account, which he argued was enough of a payoff to justify maintaining a Google+ account — at least for now, Cephalexin over the counter, anyway.

Social media guru Robert Scoble, on the other hand, was disappointed in Pages, calling them clumsy and difficult to manage, Cephalexin For Sale. Fast Company's Mark Wilson brought up the same point and added that since Google gives individuals two options of how to engage with businesses instead of Facebook's single "Like," most people will choose the weaker option. TechCrunch's Jason Kincaid wondered what exactly that weaker option, giving the business a +1, will do.

For Slate's Farhad Manjoo, Doses Cephalexin work, the addition of Pages was too little, too late for Google+. He declared the social network dead, a victim of Google's launch-then-fix-it model that has worked so well for most of its products. "But a social network isn’t a product; it’s a place Cephalexin For Sale, ," Manjoo wrote, arguing that Google should have let its users be more free to experiment to make up for its initial deficits. Mathew Ingram of GigaOM and the New York Times' Nick Bilton countered that it's too soon to give up on the network, because Google+ is designed to be not just another social network, but instead the connective tissue integrating an entire way to experience the web. Google has some pretty good cards still its hand that can help it reach that goal, too, he said.

—

Romenesko, attribution, and hair-splitting: Jim Romenesko, the dean of media bloggers soon to semi-retire from the Poynter Institute, was pushed into a bizarre little controversy yesterday when his editor, Cephalexin without prescription, Julie Moos, wrote a post taking him to task for "incomplete attribution" in his posts — essentially, using language from the posts he's summarizing (and linking to) without putting it in quote marks. Moos wrote the post in response to questions from the Columbia Journalism Review as it develops an article on the subject.

Romenesko wasn't asked to resign (he offered his resignation twice but Moos rejected it), but he will have to follow stricter attribution guidelines and have his posts edited before they go up. 10, Is Cephalexin addictive, 000 Words' Elena Zak praised Poynter's transparency, but to most observers, this was ethical hairsplitting run amok.

Media consultant Mark Potts hit many of the main points in his defense of Romenesko, noting that no one has complained to Poynter about this in the decade he's been blogging for them. Reuters' Felix Salmon pointed to Romenesko's stature in the blogosphere and his role in establishing the field's norms: "If your guidelines go against what Jim is doing, then there might well be something wrong with your guidelines."

The Awl's Choire Sicha took the opportunity to level a more serious charge at Poynter's handling of Romenesko's blog, saying that "Poynter has worked systematically to erode a fairly noble, not particularly money-making thing as it works to boost 'engagement'" and other online-media buzzwords, Cephalexin For Sale. For his part, Romenesko himself expressed his frustration in typically understated fashion in an email to the New York Times, then tweeted that "I feel it's time to go."

—

Is future-of-news talk hurting journalism?: This week, we got the rare opportunity to have a substantive, big-picture (meta)discussion about the way we think about the future of news when the Columbia Journalism Review published a thorough critique by Dean Starkman of 'future of news' thinkers like Jeff Jarvis, Clay Shirky, Cephalexin alternatives, and Jay Rosen.

The piece is quite long, but worth a close read: In short, Starkman argued that these thinkers are undermining the most valuable form of journalism — public-service journalism — by disempowering journalists and their institutions and by wasting their limited time (and the public's) with endless, mostly useless experimentation and busywork. Instead, Starkman proposed a model built around maintaining journalism's most valued institutions, Buy Cephalexin without a prescription, arguing that "journalism needs its own institutions for the simple reason that it reports on institutions much larger than itself."

Several people objected to Starkman's argument, starting with media strategist Terry Heaton, who countered that it's not institutions the future-of-news people have a problem with, but hierarchical institutions, and former Wall Street Journal writer Jason Fry, who said that some forms of news are indeed a commodity. A few others, like Mathew Ingram of GigaOM and Steve Buttry of the Journal Register Co. Cephalexin For Sale, argued that deep reporting vs. new media mastery isn't an either/or proposition, Cephalexin no prescription, pointing to examples of news organizations like the Guardian who do both well.

Former Guardian digital editor Emily Bell also wrote about her old paper's efforts in making a similar point, arguing that the spirit of muckraking is being carried on in these digital, networked initiatives. "The opening of electronic ears and eyes is not a replacement for reporting. It should be at the heart of it. And if it is not, then the institutions that Starkman laments might be to blame," she wrote, Cephalexin For Sale. Starkman responded by arguing that it all boils down to stories, Cephalexin maximum dosage, but the future-of-news folks want to talk about something else, and here at the Lab, C.W. Anderson weighed in on with a smart post on the ways in which institutions can be forces for both good and ill.

—

A force for digital change in the newsroom: The New York Times announced this week the retirement (effective the end of the year) of one of the pioneers of news on the web — Martin Nisenholtz, a senior vice president at the paper. As the Times noted, Nisenholtz has been intimately involved in just about every major technological initiative the Times has undertaken since he came on board in 1995: Launching the website, moving it into mobile media and tablets, Cephalexin description, and instituting its paywall earlier this year.

Poynter's Julie Moos put together a greatest-hits of commentary Cephalexin For Sale, by and about Nisenholtz over the years, including his prediction in early 2004 that smart phones would be a particularly influential force in changing news delivery. PaidContent's Staci Kramer talked about his lasting impact: No matter how slow (or fast) the transition seemed, "the NYT has an integrated newsroom with an understanding that digital, while it may not always be first, is equal."

Dave Winer, who helped create RSS, pointed out that Nisenholtz made the Times the first major publisher to license its stories for RSS, Cephalexin images, making a significant contribution to the growth of the open web in the process. The Lab's Joshua Benton used that story to illustrate thateven if news orgs can't invent these transformative web tools, they can still play a big role in their evolution and adoption. Media prof C.W. Anderson also noted another contribution Nisenholtz made — by allowing a scholar access to study his paper's digital efforts, he helped revitalize the field of digital media sociology.

—

A neutral way to tweet: If a few of the most recent sets of social media guidelines are any indication, news organizations are really struggling with the concept of their journalists' retweets on Twitter, Cephalexin For Sale. Several of those organizations have asked journalists not to retweet opinionated content without comment, lest they be thought of as biased themselves. Poynter's Jeff Sonderman tried to resolve that problem with an idea for an NT, Cephalexin from mexico, or neutral tweet, which people could use to retweet something while declaring their neutrality about it.

Most journalism folks on Twitter didn't like the idea, as Sonderman himself showed in his fine roundup of reaction. Many of them saw it as a way to avoid interacting naturally on Twitter, a "pacifier" or "high tech milquetoast," in the words of j-profs Jay Rosen and Matt Waite. Cephalexin For Sale, GigaOM's Mathew Ingram expanded on the idea, calling it a solution to the wrong problem. "By pretending that their journalists don’t have opinions, when everyone knows that they do, mainstream media outlets are suggesting their viewers or readers are too stupid to figure out where the truth lies," he wrote. Buy no prescription Cephalexin online, —

Reading roundup: Lots of smaller stories and discussions popping in and out of the future-of-news world this week. Here's a few of them:

— This week in News Corp. scandal: Rupert Murdoch's son, James, told British Parliament he didn't mislead them last time he talked to them. Or, as Gawker put it, he asserted that everyone's a liar except him. The Guardian's Roy Greenslade doesn't believe him, Cephalexin For Sale. Murdoch also said the company might still close its British newspaper, Cephalexin canada, mexico, india, the Sun. And we also found out News of the World hired people to spy on their hacking victims' lawyers. Guardian editor Alan Rusbridger put the scandal in perspective in a lecture.

— New York Times media critic David Carr mused on the decline of WikiLeaks as an organization and its implications for radical transparency as a movement. Dave Winer and Mathew Ingram responded by questioning why the Times hasn't supported WikiLeaks more itself.

— Andy Rooney of CBS' 60 Minutes, one of the icons of American broadcast television, died late last week at age 92. Cephalexin recreational, You can check out the obituaries from CBS and the New York Times, a set of his classic essays at Gawker, and a thoughtful remembrance by tech entrepreneur Anil Dash.

— Finally, two great pieces of advice for two groups of people: Longtime News & Record editor John Robinson for newspaper editors, and MIT's Ethan Zuckerman for media consumers (read: all of us).

Similar posts: Armour For Sale. Buy Glucophage No Prescription. Tramadol No Rx. Cipro pictures. Tramadol pharmacy. Buy cheap Armour no rx.
Trackbacks from: Cephalexin For Sale. Cephalexin For Sale. Cephalexin For Sale. Purchase Cephalexin online. Real brand Cephalexin online. About Cephalexin.

[This review was originally posted at the Nieman Journalism Lab Buy Glucophage No Prescription, on Nov. 19, 2010.]

An unpopular marriage: As I briefly noted in last week's review, the big story this week was, not surprisingly, Newsweek's merger with Tina Brown and Barry Diller's website The Daily Beast. The New York Observer, which broke the story, buying Glucophage online over the counter, had most of the newsy details — merged websites under The Daily Beast, unspecified layoffs to come, etc. — as well as the story of how the deal went down.

The Daily Beast's own Howard Kurtz had some notes on what the new organization would look like, led by Brown's assertion that whatever the new Newsweek will be, Glucophage recreational, it won't be the newsmagazine format. As The New York Times' Evelyn Rusli observed, the key asset in this deal may not be either property but instead Brown, one of the U.S.' most prominent magazine editors, Buy Glucophage No Prescription. The Wall Street Journal had more notes on Brown, and Slate's Jack Shafer dished out some advice for her.

Just about the only media figure who voiced any sort of excitement about the deal was Arianna Huffington; everyone else's responses ranged from indifference to revulsion. The New York Times' David Carr laid his derision on thick, saying the deal "marries two properties that have almost nothing in common other than the fact that they both lose lots of money." NYU professor Clay Shirky called it a farcical reprise of the AOL-Time Warner bomb. TechCrunch's Erick Schonfeld warned the two companies not to combine their brands (and it appears they won't, except online), Glucophage without prescription.

The Wall Street Journal summed up the doubters' concerns well with a list of four reasons Buy Glucophage No Prescription, for concern: Joint ventures are tough, media joint ventures are tougher, it's headed by strong-willed personalities, and it's a merger of two companies that are losing money. The last point gained the most traction, building on media reports (which Scott Rosenberg questioned) that have Newsweek on pace to lose $20 million this year and The Daily Beast on track to lose $10 million (though it was supposedly expected to turn a profit within two years). Business Insider's Henry Blodget joined the Journal in wondering how they'd make money together, and Forbes' Jeff Bercovici asked a good question: If your media venture is on track to profitability, why would you want to tie yourself to a business that's gone nowhere but down?

There were a couple of possible answers: First, as The New York Times reported, Glucophage price, the Beast's Diller has developed a sudden affinity for print publications. Also, Mediaite's Colby Hall noted that with as much content as the Beast produces, Newsweek's costs could drop pretty quickly, and Advertising Age said advertisers could be attracted by simple novelty of the new organization.

The other big piece of the deal is the fact that it will likely mean the death of Newsweek.com, despite the fact that has a far larger audience than The Daily Beast. The website's staff members are nervously awaiting their fate, but in the meantime took to Tumblr to mount a defense of Newsweek.com, praising its work while saying it has "always remained an ugly stepchild to its print grandparents, who were too busy burning money to notice." Former Newsweek.com staffer Mark Coatney chimed in, wondering what would happen to Newsweek's SEO and content deals without its own site, Buy Glucophage No Prescription. Reuters' Felix Salmon also agreed, purchase Glucophage online, saying the shutdown only makes sense as a power grab by Brown. But Advertising Age and GigaOM defended the move, saying the Beast's traffic is more valuable than Newsweek's.

—

Don't call it an email killer: Facebook made a big announcement this week, unveiling its new quasi-email, quasi-chat message system, Online buy Glucophage without a prescription,  Facebook Messages. (Want to know what it looks like. Search Engine Land has you covered.) The message we heard repeatedly Buy Glucophage No Prescription, from Facebook was that Messages is not a rival to email services like Google's Gmail. And why was that. Well, because it spent most of the weekend being hyped as a "Gmail killer." And the reason it's such a threat to email, said Charlene Li and ReadWriteWeb, is precisely because it's a lot more than email: It's the convergence of chat, email and text messaging; archived communications by friend; and a "social inbox." The gadget blog Gizmodo said we'll be giving up traditional email for it because we're all already using Facebook's interface and because it should be able to sort what's important from what's not, Glucophage no prescription.

But another Gawker blog, Lifehacker, said we shouldn't give up email for Facebook Messages, because it's meant to work with email, not like email. In addition, Glucophage results, anything you say there can't be moved elsewhere. Others were also skeptical, for a variety of reasons: Silicon Alley Insider's Matt Rosoff and the Houston Chronicle Dwight Silverman said this isn't unified communications, but just another way to get hardcore users to spend more time on Facebook, Buy Glucophage No Prescription. GigaOM's Mathew Ingram argued that many people won't use it as an email supplement if it doesn't connect to their existing email accounts. The Guardian talked to an analyst who said Facebook can't handle the task of using all of its data to optimize social messaging. Then there's the privacy issue: Salon's Dan Gillmor said we should be uncomfortable about putting all of our communications into the hands of a single company, especially Facebook.

There were three other thoughtful perspectives on what Facebook Messages means that stood out: Om Malik of GigaOM saw Messages as a critical step for Facebook in helping us stay in touch with our most intimate friends, as opposed to the more distant "second-order" friends it's been specializing in. Buy Glucophage No Prescription, And though he was off about the shape Messages would take, Nick O'Neill of All Facebook aptly placed Messages within a long-running battle between Facebook and Google for online authority.

Finally, buy Glucophage online no prescription, in a post at the Lab, Ken Doctor called for news organizations to embrace the philosophy behind Facebook Messages: "It’s about simplification, about interconnection, about consolidation." Meanwhile, in other much-less-covered email-related news: AOL announced it's relaunching its own email service, a story TechCrunch rather comically broke last Friday. Online buying Glucophage hcl, —

Yahoo goes deeper into original content: Yahoo dived deeper into the original-content pool this week with two moves: First, it added three new blogs to its seven-month-old The Upshot, building a network of originally reported news blogs. The new sites will focus on politics, national news, and media. CNN noted that the new group is being headed by a veteran of Talking Points Memo and quoted Yahoo News head Mark Walker as describing it as Yahoo's biggest original-content push yet: "Pure aggregation will only get you so far, even if you're really good at it."

Yahoo also completed its integration of Associated Content, Glucophage brand name, the content farm it bought in May, by relaunching it as the Yahoo Contributor Network. Through the network, Yahoo plans to post at least 2,000 articles of search engine-friendly content a day, paying its 400,000 contributors a small fee upfront, followed by bonused based on pageviews, Buy Glucophage No Prescription. Kara Swisher of All Things Digital was skeptical of the plan.

—

Some eye-opening iPad stats: We got a few more pieces of data on iPad use in the past week, including some quick, interesting stats from The Wall Street Journal showing that iPad use jumps in the evening, Effects of Glucophage, while computer use drops. (Smart phone is relatively steady throughout the day.) This seems to correlate with what many have suspected about the iPad — that it's being used as more of a leisure device than phones or computers.

Business Insider had quite a few more fascinating stats from its survey of iPad owners, finding, among other things, that most iPad owners are using their iPads more than when they first got the device, 30% are using it as their primary computer, they're spending as much time with it as they are their laptops, is Glucophage safe, and about equal numbers of people use the browser and apps to read news. Poynter's Damon Kiesow isn't reading much into the data Buy Glucophage No Prescription, , but he did find it surprising that about a third are reading news primarily on apps, considering how few news orgs have them out right now. That's good news for major media outlets, he said, though it doesn't mean much for the little guys.

Meanwhile, News Corp.'s James Murdoch said he thinks news apps for mobile devices like the iPad cannibalize newspaper sales, Glucophage forum, something Reuters' Felix Salmon wasn't sure about, and Poynter's Kiesow wasn't buying without seeing some data. News Corp., by the way, is reported to be close to launching its much-talked-about tablet news publication, and The Economist dropped its own iPad app this week.

—

Google News' crediting experiment: One cool little story worth highlighting: Google News announced it's introducing two tags for articles that will help indicate which articles were the first to report a story and which articles are essentially the same story on different sites. It's an experiment, as the Lab's Megan Garber noted, in finding out how willing news organizations are to give online credit where credit is due, Buy Glucophage No Prescription. As Search Engine Land's Matt McGee pointed out, ordering Glucophage online, they're based on the honor system, so there's nothing to stop spammers (or legit news organizations) from misusing the tags. CUNY j-prof C.W. Anderson wondered if the tags might provide some new research opportunities for scholars.

—

Reading roundup: Here's everything else worth taking a look at before you hit the weekend:

— Over at the National Sports Journalism Center, Jason Fry has written a wonderful column on the importance of the link to sports journalism, and it goes for all journalism as well. Buy Glucophage No Prescription, Elsewhere, Terry Heaton wrote about the value of the link in online advertising, a notion The Batavian's Howard Owens took issue with.

— A few paid-content tidbits: Connecticut's Valley Independent Sentinel is the latest local newspaper to make use of Journalism Online's Press+ paid-content system, The Times of London is partnering with a mobile broadband provider for a free-access offer at its website, and two new-media companies are working on an online news "EZ Pass."

— A couple pieces from last week I missed: Mashable's Vadim Lavrusik and Eastern Illinois j-prof Bryan Murley both urged j-schools to push some more boundaries in their teaching of news and technology.

— Weekly fuel for the pessimists among us: Poynter's Rick Edmonds on the signs that newspapers are still failing financially, and the nonprofit news site The Washington Independent announced it's closing up shop.

— And in the food-for-thought category: Jonathan Stray on the real value of social news, and CUNY j-prof C.W. Anderson at the Lab on journalism and online community. "We can’t will authentic community into being. It sort of sneaks up on us. And just as quickly — as soon as we turn our heads — it’s gone.".

Similar posts: Synthroid Cost. Lipitor No Rx. Purchase Retin A. Glucophage from canadian pharmacy. Where can i buy cheapest Flagyl online. Glucophage photos.
Trackbacks from: Buy Glucophage No Prescription. Buy Glucophage No Prescription. Buy Glucophage No Prescription. Is Glucophage safe. Glucophage coupon. Purchase Glucophage online no prescription.